Solid Biosciences's total assets for Q3 2024 were $211.83M, a decrease of -8.29% from the previous quarter. SLDB total liabilities were $44.80M for the fiscal quarter, a 18.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.